SCHEMBL19852541

SCHEMBL19852541

CC(F)O[C@H]1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.45
▸ HPGD P15428 1/20 0.44
▸ PIK3CD O00329 2/20 0.44
▸ PRMT5 O14744 1/20 0.43
▸ WDR77 Q9BQA1 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GPR119 Q8TDV5 4/20 0.41
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768828 0.91 HPGD (0.50) HPGDRECQLEPHX1ALDH1A1MAPT
SCHEMBL18015117 0.90 HPGD (0.46) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL18015122 0.90 HPGD (0.46) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL18015131 0.90 HPGD (0.46) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL3332529 0.88 HPGD (0.47) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL15802795 0.88 HPGD (0.47) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL3332523 0.88 HPGD (0.47) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL19768827 0.88 NR1H2 (0.46) USP30HPGDPRMT5WDR77RECQL
SCHEMBL19674641 0.87 PIK3CD (0.47) USP30HPGDPIK3CDPRMT5WDR77
SCHEMBL18839712 0.84 USP30 (0.46) USP30HPGDPIK3CDPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 — — WO disclosed
Send feedback